Mechanisms Underlying Late-Life Prolonged Grief Disorder

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-89
SponsorMedical College of Wisconsin

About this trial

After losing a loved one, most successfully navigate acute grief and adapt to the loss within about 1 year, but in about 10%, prolonged grief disorder (PGD) ensues. This study is anticipated to provide novel evidence regarding the neurobiological mechanisms of PGD in older adults. The biological alterations identified here could provide targets to elucidate how currently available therapies work and inform novel mechanism-based interventions for treating late-life PGD.

Eligibility criteria

Qualifiers

Male or female greater than or equal to 40 years of age

Bereavement >6 months

Score greater than or equal to 25 on the Inventory of Complicated Grief (ICG)

Presence of PGD (subsyndromal and syndromal)

Disqualifiers

Delirium/unstable medical conditions

Lifetime history of neurological illnesses: seizures, stroke, dementia of any -etiology, severe head injury, brain tumor or surgery

Serious back, joint or neck injuries within the past 3 months

Currently practicing yoga

Trial design

Treatments tested in this trial

  • Iyengar Yoga
  • Health Education Control
  • Waitlist Control to Crossover

Treatment groups

126 Participants
are divided into 3 treatment groups

Sponsors and collaborators